REGISTER NOW
SUBMIT ABSTRACT
7th World Cancer Congress - 2022 | Bangalore 2nd Global Surgery Summit - 2022 | Bangkok | Thailand 7th World Cancer Congress - 2022 | Bangalore
Normal Registration Fees Closes: 21st November, 2024, 2nd Phase Abstract Submission Closes: 27th November, 2024
7th World Cancer Congress - 2022 | Bangalore

ORGANISED BY
HIGHLIGHTS OF THE CONFERENCE
  • Explore the implications of a changing health system on cancer prevention and control.
  • Impact of disparities on access and quality of cancer prevention and control.
  • Cancer prevention and focus on primary prevention.
  • Identify how to effectively address cancer survivorship across the continuum.
  • New innovations in Cancer research and technology.
  • Global cancer initiatives.
  • Better Clinical Practice.


INVITATION TO 9TH WORLD CANCER CONGRESS - 2025

Arjyopa Healthcare welcomes you to attend the 9th World Cancer Congress - 2025 during April 25th - 26th, 2025 at Radission Blu Edwardin, London, UK. We cordially invite all the participants interested in sharing their knowledge and research in the arena of Oncology and Cancer Research. From feedback received, the previous Congresses 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024 resulted in fruitful collaborations and rewarding experiences for the delegates who left the events with concrete tools and solutions that helped them enhance their work practice and impact. As hosts, we already feel very excited to create the same energetic and inspiring atmosphere during the Congress week, adding local flavors and new perspectives such as the role of complementary treatment in cancer to the programme.

In 2022 there were 288,753 new cases of cancer diagnosed in England. In England the Overall incidence of cancer was 21% higher in men than in women in 2022. Over half of people newly diagnosed with cancer are aged over 70. Among people aged 25 to 59, incidence rates are higher in women than in men. Among people aged over 65, incidence rates are around 50% higher in men than in women. Over half of cancers fall into four types: prostate, breast, lung, and colorectal. Cancer is the cause of just over a quarter of all deaths in England in a typical year. In the year 2021 in England alone, 134,802 people died from cancer.

We expect thousands of worldwide cancer and health experts to converge to our capital city in April, 2025, and take advantage of this major educational platform to further 'Strengthen. Inspire. Deliver' the global cancer control momentum

The 9th World Cancer Congress - 2025 will also explore the new ideas and concepts on global scale and the topics Cancer Biology & Genetics, Organ-Defined Cancers, Oncology: Sub- Specialities, Radiation Oncology, Surgical Oncology, Cancer & Stem Cell Therapy, Precision Cancer Medicine & Oncology, Cancer Biomarkers, Cancer Epidemiology, Cancer Prevention & Research, Cancer Therapy & Treatments, Cancer Pharmacology, Cancer Vaccines, Cancer Immunology & Immunotherapy, Oncology Nursing and Care, Complementary & Alternative Methods and Cancer, Cancer Awareness and Survival, Cancer: Lifestyle and Nutrition, Cancer: Psychological & Social Aspects. Meet leading oncologist, cancer researchers, pharmaceutical leaders, scientists, clinicians, physicians, doctors, health care professionals, molecular diagnosticians, clinicians, researchers, Executives/Managers and Business Delegates, Director of Laboratories, Universities, Industries, Investigators, Post-Doctoral Fellows, Research & Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research organizations, societies and associations.

We look forward to the honor of welcoming you at London during conference.


Scientific Session

  • Track 1: Bladder Cancer
  • Track 2: Bone Cancer
  • Track 3: Brain Cancer
  • Track 4: Breast Cancer
  • Track 5: Cancer Genetics & Genomics
  • Track 6: Cancer Immunotherapy & Vaccines
  • Track 7: Cancer Metabolism
  • Track 8: Cell Signalling & Regulation
  • Track 9: Cell-Based Therapy
  • Track 10: Chemical Biology
  • Track 11: Chronic Myeloid Leukemia
  • Track 12: Chronic Lymphocytic Leukemia
  • Track 13: Developmental Biology
  • Track 14: Endocrine Cancer
  • Track 15: Epidemiology
  • Track 16: Epigenetics
  • Track 17: Exercises Oncology
  • Track 18: Imaging
  • Track 19: Immunology
  • Track 20: Lung Cancer
  • Track 21: Lymphoma
  • Track 22: Palliative Care
  • Track 23: Genome Integrity
  • Track 24: Gynecologic Cancer
  • Track 25: Microbiome & Inflammation
  • Track 26: Molecular Pathology & Diagnostics
  • Track 27: Multiple Myeloma
  • Track 28: Nanotechnology
  • Track 29: Neuroscience & Neuro-Oncology
  • Track 30: Renal Cell Carcinoma
  • Track 31: Sarcoma
  • Track 32: Skin Cancer
  • Track 33: Side Effect Management
  • Track 34: Solid Tumor Oncogenesis
  • Track 35: Stem Cells
  • Track 36: Structural Biology
  • Track 37: Systems Biology
  • Track 38: Targeted Therapy
  • Track 39: Tumor Micro Environment
  • Track 40: Urologic Cancers
  • Track 41: Pancreatic Cancer
  • Track 42: Pediatric Cancer
  • Track 43: Prostate Cancer
  • Track 44: Gastrointestinal Cancer
  • Track 45: Head & Neck Cancer
  • Track 46: Hematologic Malignancies
  • Track 47: HPV & Cervical Cancer
  • Track 48: Metastasis & Drug Resistanc



SUBMIT ABSTRACT

Authors are invited to submit abstract(s) using the submission form on this page. Abstracts should contain sufficient detail on the techniques used and the results, which will be shown. You will receive a confirmation when the abstract has been received. Please contact the conference secretariat if you did not receive confirmation within 5 working days. Submission implies the intent of at least one author to register, attend the symposium and present the paper orally or in poster format. Contributions will only be finally accepted after registration and payment of the conference fee. The abstract will be reviewed, and you will be notified of acceptance.
  • The entire body of the abstract, excluding tables, must not exceed 250 words. Spaces are not included in this number. Title, authors’ names, affiliations, figures, and tables are not included in the character count.
  • The abstract may be structured (i.e., abstracts divided into sections using terms such as Introduction, Methods, Results, Conclusions, etc.) or unstructured.
  • Do not use bold type or underline formatting. Italic type is acceptable.
  • Text may be in multiple paragraphs.
  • Any references should be noted as citations within the text and not as footnotes at the end
Important Dates
2nd Phase Abstract Submission Deadline: 15th November, 2024
Extended Early Bird Registration Closes: 21st September, 2024
Click Here to Submit Abstract
Click Here to Download Information Brochure


7th World Cancer Congress - 2022 | Bangalore
7th World Cancer Congress - 2022 | Bangalore

SUPPORTING JOURNALS
7th World Congress on Drug Discovery and Development - 2022 | Bangalore

CONTACT US AT

Conference Secretariat
UNITED STATES
ARJYOPA HEALTHCARE
16192 Coastal Hwy., Lewes, DE 19958, US


INDIA
ARJYOPA HEALTHCARE
H. No -02, Floor No 1&2, DumDum
Kolkata - 700078, West Bengal, India

WRITE TO US


7th World Congress on Drug Discovery and Development - 2022 | Bangalore

PHOTO GALLERY(OUR PAST EVENTS)
7th World Cancer Congress - 2022 | Bangalore
ORGANISED BY

7th World Cancer Congress - 2022 | Bangalore




MAIL US AT
Sponsorship/Exhibitions: [email protected]
General Enquiries: [email protected]


Copyright@2014-2023, Arjyopa Healthcare. All Right Reserved


7th World Cancer Congress - 2022 | Bangalore